Frontlight ResearchEarly access
Hodgkin lymphoma trials in United States
77 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplectDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
- Where
- Davis, Fresno, Irvine, La Jolla, Los Angeles, San Francisco
- Age
- 18 years and over
- People
- 38
- Run by
- Michael Spinner, MD
See details and how to joinNCT07021989 - Phase 2Taking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Austin, Charlotte, Chicago, Columbus, Duarte, Houston, Iowa City, Jacksonville, Milwaukee, Nashville, New Brunswick, New York, Overland Park, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, San Antonio, St Louis, Tampa, Waukee
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - No phaseTaking peopleEstablishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
- Where
- Boston
- Age
- 18 years and over
- People
- 1,500
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT00131014 - Phase 1/2Taking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Atlanta, Boston, Duarte, Houston, Miami, New York, Philadelphia
- Age
- 12 years and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - Early phase 1Taking peopleDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Where
- Baltimore
- Age
- 18 years and over
- People
- 8
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06398457 - Phase 1Taking peopleCD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
- Where
- Houston
- Age
- 12 years to 75 years
- People
- 60
- Run by
- Baylor College of Medicine
See details and how to joinNCT02917083 - Phase 1Taking peopleConstitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
- Where
- Houston
- Age
- 12 years to 75 years
- People
- 90
- Run by
- Baylor College of Medicine
See details and how to joinNCT06176690 - Phase 3Taking peopleA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Columbus, Fort Wayne, St. Petersburg, Tacoma, Westbrook
- Age
- 18 years and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - Phase 2Taking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - Phase 2Taking peopleAscorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
- Where
- Eau Claire, La Crosse, Mankato, Rochester
- Age
- 18 years and over
- People
- 80
- Run by
- Mayo Clinic
See details and how to joinNCT03418038 - Phase 1Not yet taking people in United StatesPositron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity
- Where
- St Louis
- Age
- 21 years to 99 years
- People
- 36
- Run by
- Washington University School of Medicine
See details and how to joinNCT07838649 - Phase 2Taking peopleA Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
- Where
- Houston
- Age
- 18 years and over
- People
- 36
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05615636 - Phase 1Taking peopleSafety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- Where
- Aurora, Austin, Denver, Duarte, Kansas City, Madison, New York
- Age
- 18 years to 100 years
- People
- 79
- Run by
- Marker Therapeutics, Inc.
See details and how to joinNCT05798897 - Phase 1Taking peoplePhase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
- Where
- Houston
- Age
- 18 years to 75 years
- People
- 60
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07444632 - No phaseTaking peopleCardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
- Where
- Memphis
- Age
- 18 years and over
- People
- 100
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06421987 - Phase 2Taking peoplePhase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
- Where
- Houston
- Age
- 2 years to 21 years
- People
- 15
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07551583 - No phaseTaking peopleIntegration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
- Where
- Memphis
- People
- 100
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07514819 - Phase 1Taking peopleCD45BE-HSPC + CART-45 Cells
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 42
- Run by
- University of Pennsylvania
See details and how to joinNCT07451054 - Phase 1/2Taking peoplePhase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
- Where
- Houston
- Age
- 12 years to 80 years
- People
- 80
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05092451 - Phase 1/2Taking peopleATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 31
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06090864 - Phase 2Not yet taking people in United StatesPhase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
- Where
- Houston
- Age
- 18 years to 75 years
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07164469 - Phase 2Taking peopleRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Where
- Orange
- Age
- 18 years and over
- People
- 75
- Run by
- University of California, Irvine
See details and how to joinNCT06580002 - Phase 3Taking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Miami, New York, Stanford
- Age
- 16 years to 69 years
- People
- 1,042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - No phaseTaking peopleA Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Where
- Akron, Amarillo, Ann Arbor, Atlanta, Augusta, Aurora, Baltimore, Beech Grove, Bethesda, Birmingham, Boston, Brandywine, Buffalo, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Denver, Detroit, Duarte, Durham, Fort Sam Houston, Fort Worth, Gainesville, Gilbert, Glendale, Grand Rapids, Hackensack, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, La Jolla, Lake Sucess, Little Rock, Loma Linda, Los Angeles, Louisville, Lubbock, Madison, Maywood, Memphis, Miami, Milwaukee, Morgantown, Nashville, New Brunswick, New Haven, New Hyde, New Orleans, New York, Oakland, Oklahoma City, Omaha, Orange, Orlando, Park Ridge, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Stanford, St Louis, Stony Brook, St. Petersburg, Tampa, The Bronx, Tucson, Washington D.C., Westwood, Winston-Salem, Worcester, Zion
- People
- 99,999
- Run by
- Center for International Blood and Marrow Transplant Research
See details and how to joinNCT01351545 - No phaseTaking peopleHalt Aging in Survivors of Blood Cancers
- Where
- Omaha
- Age
- 50 years and over
- People
- 180
- Run by
- University of Nebraska
See details and how to joinNCT07292272